Seaton K G, Patz E F, Goodman P C
Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710.
AJR Am J Roentgenol. 1995 Mar;164(3):589-91. doi: 10.2214/ajr.164.3.7532350.
This study evaluates small-bore catheter thoracostomy combined with doxycycline sclerotherapy for palliative treatment of presumed malignant pleural effusions.
Forty-seven consecutive patients referred from the medical oncology department to the thoracic radiology section with known primary malignant tumors and symptomatic pleural effusions over a 2-year period were treated with small-bore pleural catheter drainage followed by doxycycline sclerotherapy. Of the 47 patients, 20 (43%) died less than 30 days after sclerotherapy, one (2%) died without radiographic follow-up, and five (11%) were lost to follow-up. Twenty-one patients formed the study group. Response to treatment was defined based on findings on follow-up chest radiographs obtained 30 days after sclerotherapy as complete (no reaccumulation of pleural effusion), partial (accumulation above postpleurodesis level but below that at presentation), or as a failure (reaccumulation to the amount seen at presentation).
Seventeen (81%) evaluable patients showed complete response to sclerotherapy, three (14%) showed a partial response, and one (5%) showed no response. All complete and partial responders were clinically improved with resolution of their shortness of breath. Therefore, 95% of evaluable patients had clinically and radiographically successful treatment. Six patients underwent sclerotherapy when their tube output was greater than 100 ml/24 hr. Five of the six had completely successful pleurodesis, and one failed to respond. Two (10%) of the 21 patients had greater than 150 ml drainage in the 24 hr after initial doxycycline administration and were therefore given a second dose of intrapleural doxycycline. Both of these patients subsequently had less than 150 ml drainage in an additional 24-hr observation period and went on to complete response. Complications included three patients (14%) with mild discomfort at the chest tube site during drainage, one patient (5%) with pain during instillation of doxycycline, and one patient (5%) with transient fever (38.3 degrees C body temperature) one day after sclerotherapy.
Small-bore catheter thoracostomy followed by doxycycline sclerotherapy successfully resolves symptomatic pleural effusion in patients with known primary malignant tumors.
本研究评估细管胸腔造口术联合强力霉素硬化疗法对疑似恶性胸腔积液的姑息治疗效果。
在两年期间,47例从肿瘤内科转诊至胸放射科的患者,已知患有原发性恶性肿瘤且有症状性胸腔积液,接受了细管胸腔引流,随后进行强力霉素硬化疗法。47例患者中,20例(43%)在硬化疗法后30天内死亡,1例(2%)未进行影像学随访即死亡,5例(11%)失访。21例患者组成研究组。根据硬化疗法后30天获得的胸部X线片结果,将治疗反应定义为完全缓解(胸腔积液无再积聚)、部分缓解(胸腔积液积聚在胸膜固定术后水平以上但低于初始水平)或治疗失败(胸腔积液再积聚至初始水平)。
17例(81%)可评估患者对硬化疗法显示完全缓解,3例(14%)显示部分缓解,1例(5%)无缓解。所有完全缓解和部分缓解的患者临床症状均有改善,气短症状消失。因此,95%的可评估患者在临床和影像学上治疗成功。6例患者在胸腔引流管引流量大于100 ml/24小时时接受了硬化疗法。6例中的5例胸膜固定术完全成功,1例无反应。21例患者中有2例(10%)在首次给予强力霉素后的24小时内引流量大于150 ml,因此给予第二剂胸腔内强力霉素。这2例患者随后在额外的24小时观察期内引流量均小于150 ml,并最终达到完全缓解。并发症包括3例患者(14%)在引流期间胸腔引流管部位有轻度不适,1例患者(5%)在注入强力霉素时有疼痛,1例患者(5%)在硬化疗法后一天出现短暂发热(体温38.3摄氏度)。
细管胸腔造口术联合强力霉素硬化疗法成功解决了已知原发性恶性肿瘤患者的症状性胸腔积液问题。